Early effect of pravastatin on serum soluble CD40L, matrix metalloproteinase-9, and C-reactive protein in patients with acute myocardial infarction.
Li
Jiang
J
Department of Cardiology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhao
Shui-Ping
SP
Peng
Dao-quan
DQ
Xu
Zhu-mei
ZM
Zhou
Hong-nian
HN
D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000378:metabolism; D023201:CD40 Ligand / Q000097:blood; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000097:blood; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy* / Q000201:enzymology; D017035:Pravastatin / Q000494:pharmacology* / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D023201:CD40 Ligand; D002097:C-Reactive Protein; D020780:Matrix Metalloproteinase 9; D017035:Pravastatin